JPH0538732B2 - - Google Patents
Info
- Publication number
- JPH0538732B2 JPH0538732B2 JP9858687A JP9858687A JPH0538732B2 JP H0538732 B2 JPH0538732 B2 JP H0538732B2 JP 9858687 A JP9858687 A JP 9858687A JP 9858687 A JP9858687 A JP 9858687A JP H0538732 B2 JPH0538732 B2 JP H0538732B2
- Authority
- JP
- Japan
- Prior art keywords
- tablets
- particle size
- tablet
- cellulose
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002245 particle Substances 0.000 claims description 51
- 239000000843 powder Substances 0.000 claims description 29
- 229920001503 Glucan Polymers 0.000 claims description 17
- 239000007916 tablet composition Substances 0.000 claims description 15
- 239000001913 cellulose Substances 0.000 description 76
- 229920002678 cellulose Polymers 0.000 description 71
- 235000010980 cellulose Nutrition 0.000 description 71
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 23
- 239000008187 granular material Substances 0.000 description 22
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 18
- 238000009472 formulation Methods 0.000 description 17
- 239000004480 active ingredient Substances 0.000 description 14
- 229960005070 ascorbic acid Drugs 0.000 description 13
- 235000010323 ascorbic acid Nutrition 0.000 description 13
- 239000011668 ascorbic acid Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000000465 moulding Methods 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 11
- 229960003893 phenacetin Drugs 0.000 description 11
- 238000005204 segregation Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 239000000654 additive Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 238000007907 direct compression Methods 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 238000007906 compression Methods 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000019814 powdered cellulose Nutrition 0.000 description 5
- 229920003124 powdered cellulose Polymers 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 238000004438 BET method Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 239000007884 disintegrant Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 229920003084 Avicel® PH-102 Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CHRHZFQUDFAQEQ-UHFFFAOYSA-L calcium;2-hydroxyacetate Chemical compound [Ca+2].OCC([O-])=O.OCC([O-])=O CHRHZFQUDFAQEQ-UHFFFAOYSA-L 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000009702 powder compression Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9858687A JPS63267731A (ja) | 1987-04-23 | 1987-04-23 | 錠剤組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9858687A JPS63267731A (ja) | 1987-04-23 | 1987-04-23 | 錠剤組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63267731A JPS63267731A (ja) | 1988-11-04 |
| JPH0538732B2 true JPH0538732B2 (enrdf_load_html_response) | 1993-06-10 |
Family
ID=14223752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9858687A Granted JPS63267731A (ja) | 1987-04-23 | 1987-04-23 | 錠剤組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63267731A (enrdf_load_html_response) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008078730A1 (ja) | 2006-12-26 | 2008-07-03 | Translational Research, Ltd. | 経鼻投与用製剤 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW260612B (enrdf_load_html_response) * | 1993-01-05 | 1995-10-21 | Asahi Chemical Ind | |
| CA2414945C (en) | 2000-07-05 | 2006-07-04 | Asahi Kasei Kabushiki Kaisha | Cellulose powder |
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
| AU2003220808B2 (en) | 2003-03-27 | 2008-08-21 | Bioactis Limited | Powder medicine applicator for nasal cavity |
| CN100465214C (zh) | 2003-05-30 | 2009-03-04 | 旭化成化学株式会社 | 纤维素粉末 |
| CN100402585C (zh) | 2004-01-30 | 2008-07-16 | 旭化成化学株式会社 | 多孔纤维素聚集体以及包含这种聚集体的组合物成形品 |
| US8673360B2 (en) | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
| BRPI0608113B8 (pt) | 2005-04-22 | 2021-07-27 | Asahi Kasei Chemicals Corp | agregado de celulose porosa, método para produzir o mesmo, e, composição de compactação |
| EP2287234B1 (en) | 2008-05-21 | 2016-03-23 | Asahi Kasei Chemicals Corporation | Cellulose powder having excellent segregation preventive effect, and compositions thereof |
| JP2012526726A (ja) | 2009-05-15 | 2012-11-01 | 株式会社新日本科学 | 薬物動態が改善された鼻腔内用薬学的組成物 |
| GB2472327B (en) | 2009-07-31 | 2013-03-13 | Shin Nippon Biomedical Lab Ltd | Intranasal granisetron and nasal applicator |
| CN102958980B (zh) * | 2010-06-29 | 2015-05-27 | 旭化成化学株式会社 | 含有纤维素和无机化合物的复合粒子 |
| JP6216074B2 (ja) * | 2014-08-12 | 2017-10-18 | 旭化成株式会社 | 微小セルロース粉末 |
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
-
1987
- 1987-04-23 JP JP9858687A patent/JPS63267731A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008078730A1 (ja) | 2006-12-26 | 2008-07-03 | Translational Research, Ltd. | 経鼻投与用製剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63267731A (ja) | 1988-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0538732B2 (enrdf_load_html_response) | ||
| JP6706245B2 (ja) | 微結晶性セルロースを含む直接圧縮可能な組成物 | |
| GB1603533A (en) | Excipients and their use | |
| JP2994956B2 (ja) | 低置換度ヒドロキシプロピルセルロース、その組成物およびその錠剤 | |
| NZ517931A (en) | Granules based on starch and lactose | |
| US11433031B2 (en) | Method for manufacturing acetaminophen preparation | |
| EP2496261B1 (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| JP3534130B2 (ja) | 医薬品組成物 | |
| JP3595765B2 (ja) | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 | |
| US5985323A (en) | Microcrystalline cellulose/alginate wet granulation excipient/binder | |
| WO2008020990A1 (en) | New direct compressible excipient blend | |
| JP2006143650A (ja) | 付着性の高い薬物を含有する錠剤の製造方法 | |
| JP4480060B2 (ja) | ユビデカレノン混合粉体および錠剤の製造方法 | |
| JP5442609B2 (ja) | セルロース組成物 | |
| JP2518854B2 (ja) | 固形製剤の製法 | |
| WO2020026881A1 (ja) | 崩壊剤成分及び微小繊維状セルロースを含む崩壊性固形物 | |
| US20230255907A1 (en) | Tablet and method for manufacturing same | |
| JPH11228429A (ja) | 固形安中散製剤 | |
| JP7714271B1 (ja) | コプロセス添加剤 | |
| JPH0526762B2 (enrdf_load_html_response) | ||
| JP2001347153A (ja) | 錠剤の製造方法 | |
| JP2000239186A (ja) | 錠剤用崩壊剤 | |
| JPH11286456A (ja) | 複合粉体組成物及び錠剤 | |
| KR20110033171A (ko) | 직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형 | |
| HK1262022A1 (en) | Method for manufacturing acetaminophen preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |